Smoking cessation after 12 months with multi-component therapy

Authors

  • Antònia Raich Unidad de Tabaquismo (Smoking Cessation Unit), Althaia Xarxa Assistencial Universitària de Manresa FP. Departamento de Ciencias Clínicas (Dept. of Clinical Sciences), Campus de Bellvitge, Facultat de Medicina, Universitat de Barcelona.
  • Jose Maria Martínez-Sánchez Unidad de Control del Tabaquismo (Smoking Control Unit), Institut Català d’Oncologia (Catalonian Institute of Cancer) (ICO-IDIBELL). Unidad de Bioestadística (Biostatistics Unit), Departamento de Ciencias Básicas (Dept. of Basic Sciences), Universitat Internacional de Catalunya, Sant Cugat del Vallès.
  • Emili Marquilles Unidad de Tabaquismo (Smoking Cessation Unit), Althaia Xarxa Assistencial Universitària de Manresa FP.
  • Lídia Rubio Unidad de Tabaquismo (Smoking Cessation Unit), Althaia Xarxa Assistencial Universitària de Manresa FP.
  • Marcela Fu Unidad de Control del Tabaquismo (Smoking Control Unit), Institut Català d’Oncologia (Catalonian Institute of Cancer) (ICO-IDIBELL).
  • Esteve Fernández Unidad de Control del Tabaquismo (Smoking Control Unit), Institut Català d’Oncologia (Catalonian Institute of Cancer) (ICO-IDIBELL). Departamento de Ciencias Clínicas (Dept. of Clinical Sciences), Campus de Bellvitge, Facultat de Medicina, Universitat de Barcelona.

DOI:

https://doi.org/10.20882/adicciones.192

Keywords:

multimodal treatment, smoking cessation, mental disorders, heavy smokers.

Abstract

Smoking is one of the most important causes of morbidity and mortality in developed countries. One of the priorities of public health programmes is the reduction of its prevalence, which would involve millions of people quitting smoking, but cessation programs often have modest results, especially within certain population groups. The aim of this study was to analyze the variables determining the success of a multicomponent therapy programme for smoking cessation. We conducted the study in the Smoking Addiction Unit at the Hospital of Manresa, with 314 patients (91.4% of whom had medium or high-level dependency). We observed that higher educational level, not living with a smoker, following a multimodal programme for smoking cessation with psychological therapy, and pharmacological treatment are relevant factors for quitting smoking. Abstinence rates are not associated with other factors, such as sex, age, smoking behaviour characteristics or psychiatric history. The combination of pharmacological and psychological treatment increased success rates in multicomponent therapy. Psychological therapy only also obtained positive results, though somewhat more modest.

References

Alonso-Pérez, F., Alonso-Cardeñoso, C., García-González, J. V., Fraile-Cobos, J. M., Lobo-Llorente, N., y Secades-Villa, R. (2014). Effectiveness of a multicomponent smoking cessation intervention in primary care. Gaceta Sanitaria, 28, 222-224.

Baer J. S., y Marlatt G. A. (1991). Maintenance of smoking cessation. Clinics in Chest Medicine, 12, 793-800.

Bauld, L., Bell, K., McCullough, L., Richardson, L., y Greaves, L. (2010). The effectiveness of NHS smoking cessation services: a systematic review. Journal of Public Health, 32, 71-82.

Becoña E., y Vazquez F. L. (1998).The course of relapse across 36 months for smokers from a smoking-cessation program. Psychological Reports; 82:143-146.

Becoña, E., y Míguez, M. C. (2008). Group behavior therapy for smoking cessation. Journal of Groups in Addiction & Recovery, 3, 63-78.

Belleudi, V., Bargagli, A. M., Davoli, M., Di Pucchio, A., Pacifici, R., Pizzi, E., ... y Perucci, C. A. (2006). [Characteristics and effectiveness of smoking cessation programs in Italy. Results of a multicentric longitudinal study]. Epidemiologia e Prevenzione, 31, 148-157.

Bjornson, W., Rand, C., Connett, J. E., Lindgren, P., Nides, M., Pope, F., ... y O’Hara, P. (1995). Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health, 85, 223-230.

Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., ... y Miller, I. W. (2001). Cognitive–behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480.

Cahill, K., Stevens, S., y Lancaster, T. (2014). Pharmacological treatments for smoking cessation. JAMA, 311, 193-194.

Cepeda-Benito, A., Reynoso, J. T., y Erath, S. (2004). Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. Journal of Consulting and Clinical Psychology, 72, 712-722.

de Leon, J., Diaz, F. J., Becoña, E., Gurpegui, M., Jurado, D., y Gonzalez-Pinto, A. (2003). Exploring brief measures of nicotine dependence for epidemiological surveys. Addictive Behaviors, 28, 1481-1486.

Fagerström, K., y Aubin, H. J. (2009). Management of smoking cessation in patients with psychiatric disorders. Current Medical Research and Opinion, 25, 511-518.

Fernández, E., Carné, J., Schiaffino, A., Borràs, J., Saltó, E., Tresserras, R., ... y Segura, A. (1998). [Determinants of quitting smoking in Catalonia, Spain]. Gaceta Sanitaria, 13, 353-360.

Fernandez, E., Garcia, M., Schiaffino, A., Borras, J. M., Nebot, M., y Segura, A. (2001). Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Preventive Medicine, 32, 218-223.

Fernández, E., Schiaffino, A., Borrell, C., Benach, J., Ariza, C., Ramon, J. M., ... y Kunst, A. (2006). Social class, education, and smoking cessation: long-term follow-up of patients treated at a smoking cessation unit. Nicotine & Tobacco Research, 8, 29-36.

Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., y Curry, S. J. (2009). Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services; May 2008.

Garrison, G. D., y Dugan, S. E. (2009). Varenicline: a first-line treatment option for smoking cessation. Clinical Therapeutics, 31, 463-491.

Hajek, P., Stead, L. F., West, R., Jarvis, M., Hartmann-Boyce, J., y Lancaster, T. (2013). Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev, 8.

Hall, S. M., Humfleet, G. L., Muñoz, R. F., Reus, V. I., Robbins, J. A., y Prochaska, J. J. (2009). Extended treatment of older cigarette smokers. Addiction, 104, 1043-1052.

Haustein, K. O. (2004). [Smoking and low socio-economic status]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 67, 630-637.

Hays, J. T., Ebbert, J. O., y Sood, A. (2009). Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline. In Mayo Clinic Proceedings, 84, 730-736.

Hays, J. T., Leischow, S. J., Lawrence, D., y Lee, T. C. (2010). Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Nicotine & Tobacco Research, 12, 574-581.

Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., y Fagerström, K. O. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.

Himelhoch, S., y Daumit, G. (2003). To whom do psychiatrists offer smoking-cessation counseling?. American Journal of Psychiatry, 160, 2228-2230.

Killen, J. D., Fortmann, S. P., Schatzberg, A. F., Arredondo, C., Murphy, G., Hayward, C., ... y Pandurangi, M. (2008). Extended cognitive behavior therapy for cigarette smoking cessation. Addiction, 103, 1381-1390.

Likura, Y. (2010). [Classification of OCD in terms of response to behavior therapy, manner of onset, and course of symptoms]. Seishin Shinkeigaku Zasshi= Psychiatria et Neurologia Japonica, 113, 28-35.

Marlatt, G. A., Curry, S., y Gordon, J. R. (1988). A longitudinal analysis of unaided smoking cessation. Journal of Consulting and Clinical Psychology, 56, 715-720.

Middleton, E. T., & Morice, A. H. (2000). Breath carbon monoxide as an indication of smoking habit. CHEST Journal, 117, 758-763.

Nerín I. y Jané M. (2007). Libro blanco sobre mujeres y tabaco. Comite Nacional para la prevención del Tabaquismo. Zaragoza: Ministerio de Sanidad y Consumo.

Nerín I., Novella P., Beamonte A., Gargallo P.,Jimenez-Muro A. y Marqueta A.(2007) Results of smoking cessation therapy in a specialist unit. Archives of Bronconeumology, 43, 669-673.

Perkins, K. A., y Scott, J. (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research, 10, 1245-1251.

PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: (2008) update U.S. public health service clinical practice guideline executive summary. Respiratory Care, 53, 1217-1222.

Piper, M. E., Cook, J. W., Schlam, T. R., Jorenby, D. E., Smith, S. S., Bolt, D. M., y Loh, W. Y. (2010). Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine & Tobacco Research, 12, 647-657.

Ramon, J. M., y Bruguera, E. (2009). Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation. International Journal of Environmental Research and Public Health, 6, 1530-1538.

Ranney, L., Melvin, C., Lux, L., McClain, E., y Lohr, K. N. (2006). Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine, 145, 845-856.

Siahpush, M., McNeill, A., Borland, R., y Fong, G. T. (2006). Socioeconomic variations in nicotine dependence, self-efficacy, and intention to quit across four countries: findings from the International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15(suppl 3), iii71-iii75.

Silagy, C., Lancaster, T., Stead, L., Mant, D., y Fowler, G. (2004). Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Reviews, 3, CD000146.

Stead, L. F., y Lancaster, T. (2005). Group behaviour therapy programmes for smoking cessation. Cochrane Database Systematic Review, 2, CD001292.

Stead, L. F., y Lancaster, T. (2012). Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Systematic Reviews, 12, CD009670.

Stapleton, J. A., Watson, L., Spirling, L. I., Smith, R., Milbrandt, A., Ratcliffe, M., y Sutherland, G. (2008). Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction, 103, 146-154.

Tinich, C., y Sadler, C. (2007). What strategies have you found to be effective in helping patients to stop smoking?. ONS Connect, 22, 14.

Villalbí, J. R., Rodriguez-Sanz, M., Villegas, R., y Borrell, C. (2009). Changes in the population smoking patterns: Barcelona, 1983-2006. Medicina Clinica, 132, 414-419.

Wilkes, S. (2008). The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease, 3, 45-53.

Wilson, D., Wakefield, M., Owen, N., y Roberts, L. (1992). Characteristics of heavy smokers. Preventive Medicine, 21, 311-319.

Wu, P., Wilson, K., Dimoulas, P., y Mills, E. J. (2006). Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health, 6, 300.

Yáñez, A., Leiva, A., Gorreto, L., Estela, A., Tejera, E., y Torrent, M. (2013). El instituto, la familia y el tabaquismo en adolescentes. Adicciones, 25, 253-259.

Downloads

Published

2015-03-01

Issue

Vol. 27 No. 1 (2015)

Section

Originals